Discovery of pyrrolo[2,3-d]pyrimidin-4-one derivative YCH3124 as a potent USP7 inhibitor for cancer therapy
文献类型:期刊论文
作者 | Zhuang, Zhen2,3; Miao, Yu-Ling1; Song, Shan-Shan1; Leng, Guang-Tong2,3; Zhang, Xiao-Fei3; He, Qian3![]() ![]() ![]() |
刊名 | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
![]() |
出版日期 | 2024-11-05 |
卷号 | 277页码:17 |
关键词 | USP7 inhibitor Structure-activity relationships Anti-cancer pyrrolo[2,3-d]pyrimidin-4-one |
ISSN号 | 0223-5234 |
DOI | 10.1016/j.ejmech.2024.116752 |
通讯作者 | He, Jin-Xue(jinxue_he@simm.ac.cn) ; Yang, Chun-Hao(chyang@simm.ac.cn) |
英文摘要 | USP7 is one of the most studied deubiquitinating enzymes, which is involved in the regulation of multiple cell signaling pathways and has been shown to be associated with the occurrence and progression of a variety of cancers. Inhibitors targeting USP7 have been studied by several teams, but most of them lack selectivity and have low activities. Herein, we reported a serious of pyrrole[2,3-d]pyrimidin-4-one derivatives through scaffold hopping of recently reported 4-hydroxypiperidine compounds. The representative compound Z33 (YCH3124) exhibited highly potent USP7 inhibition activity as well as anti-proliferative activity against four kinds of cancer cell lines. Further study revealed that YCH3124 effectively inhibited the downstream USP7 pathway and resulted in the accumulation of both p53 and p21 in a dose-dependent manner. Notably, YCH3124 disrupted cell cycle progression through restricting G1 phase and induced significant apoptosis in CHP-212 cells. In summary, our efforts provided a series of novel pyrrole[2,3-d]pyrimidin-4-one analogs as potent USP7 inhibitors with excellent anti-cancer activity. |
WOS关键词 | STRUCTURE-GUIDED DEVELOPMENT ; CELLS |
资助项目 | National Natural Sci-ence Foundation of China[82073875] ; State Key Laboratory of Drug Research[SIMM2103ZZ-03] |
WOS研究方向 | Pharmacology & Pharmacy |
语种 | 英语 |
WOS记录号 | WOS:001294851100001 |
出版者 | ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER |
源URL | [http://119.78.100.183/handle/2S10ELR8/312830] ![]() |
专题 | 新药研究国家重点实验室 |
通讯作者 | He, Jin-Xue; Yang, Chun-Hao |
作者单位 | 1.Chinese Acad Sci, Shanghai Inst Mat Med, Canc Res Ctr, State Key Lab Drug Res, 501 Haike Rd, Shanghai 201203, Peoples R China 2.Univ Chinese Acad Sci, 19A Yuquan Rd, Beijing 100049, Peoples R China 3.Chinese Acad Sci, Shanghai Inst Mat Med, Dept Med Chem, State Key Lab Drug Res, 555 Zu Chong Zhi Rd, Shanghai 201203, Peoples R China |
推荐引用方式 GB/T 7714 | Zhuang, Zhen,Miao, Yu-Ling,Song, Shan-Shan,et al. Discovery of pyrrolo[2,3-d]pyrimidin-4-one derivative YCH3124 as a potent USP7 inhibitor for cancer therapy[J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,2024,277:17. |
APA | Zhuang, Zhen.,Miao, Yu-Ling.,Song, Shan-Shan.,Leng, Guang-Tong.,Zhang, Xiao-Fei.,...&Yang, Chun-Hao.(2024).Discovery of pyrrolo[2,3-d]pyrimidin-4-one derivative YCH3124 as a potent USP7 inhibitor for cancer therapy.EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,277,17. |
MLA | Zhuang, Zhen,et al."Discovery of pyrrolo[2,3-d]pyrimidin-4-one derivative YCH3124 as a potent USP7 inhibitor for cancer therapy".EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 277(2024):17. |
入库方式: OAI收割
来源:上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。